Fonsecaea

Fonsecaea pedrosoi

Fonsecaea is a genus of fungi within the family Herpotrichiellaceae. This genus is of significant medical importance as it contains species that are pathogenic to humans, causing a skin disease known as chromoblastomycosis. Chromoblastomycosis is a chronic fungal infection characterized by the development of nodular and verrucous skin lesions, primarily affecting the limbs. The disease is typically contracted through the inoculation of the fungal spores into the skin from a traumatic injury, especially in individuals who have close contact with soil and vegetation, as these fungi are commonly found in the environment.

Species

The genus Fonsecaea comprises several species, including:

• Fonsecaea pedrosoi – The most commonly identified species causing chromoblastomycosis.
• Fonsecaea compacta
• Fonsecaea monophora – Also known to cause chromoblastomycosis, but less frequently than F. pedrosoi.
• Fonsecaea nubica

Each species has distinct morphological characteristics, but they can cause similar clinical manifestations in humans.

Pathogenesis

The pathogenesis of chromoblastomycosis involves the implantation of the fungal spores into the skin's subcutaneous tissue, usually through a minor cut or abrasion. Once inside the host, the fungus transforms into its pathogenic form, producing sclerotic cells or muriform cells, which are highly resistant to both the host's immune response and antifungal treatments. The infection progresses slowly, and without appropriate treatment, it can spread, leading to disfiguring lesions and, in severe cases, secondary bacterial infections and complications.

Diagnosis and Treatment

Diagnosis of chromoblastomycosis is primarily based on the clinical presentation of the lesions, microscopic examination of the sclerotic bodies in tissue samples, and culture of the fungus. Molecular techniques, such as PCR, can also be used for species identification, which is crucial for epidemiological purposes and may influence treatment decisions.

Treatment of chromoblastomycosis caused by Fonsecaea species is challenging and often requires a combination of surgical excision of the lesions and long-term antifungal therapy. The most commonly used antifungal agents include itraconazole and terbinafine. However, the treatment duration is typically prolonged, and relapses are common.

Epidemiology

Chromoblastomycosis has a worldwide distribution but is most prevalent in tropical and subtropical regions, where environmental conditions favor the growth of Fonsecaea species in the soil. Individuals engaged in agricultural work or those who have direct contact with soil and vegetation are at higher risk of acquiring the infection.

Prevention

Preventive measures for chromoblastomycosis include wearing protective clothing and footwear to avoid skin trauma while working with soil or vegetation, which can reduce the risk of fungal inoculation. Early diagnosis and treatment are crucial to prevent the progression of the disease and the development of severe complications.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian